Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107K Sell
882
-550
-38% -$63.5K 0.05% 151
2025
Q4
$152K Hold
1,432
0.08% 132
2025
Q3
$120K Sell
1,432
-550
-28% -$45.3K 0.07% 138
2025
Q2
$157K Buy
1,982
+820
+71% +$65.2K 0.1% 140
2025
Q1
$104K Sell
1,162
-1,162
-50% -$108K 0.07% 149
2024
Q4
$231K Buy
2,324
+1,262
+119% +$130K 0.07% 149
2024
Q3
$121K Buy
+1,062
New +$126K 0.08% 151

Other funds holding MRK

Hara Capital's MRK Position: Q1 2026 in Review

Hara Capital reduced its Merck (MRK) stake by 38% in Q1 2026, selling an estimated $63.5K and leaving 882 shares worth $107K. The position accounts for 0.05% of the portfolio, ranked #151.

Hara Capital first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. The position peaked at $231K in Q4 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hara Capital held 882 shares of Merck worth $107K as of Q1 2026.
  • Hara Capital sold 550 Merck shares in Q1 2026, an estimated $63.5K.
  • Merck made up 0.05% of Hara Capital's portfolio in Q1 2026, its #151 holding.
  • Hara Capital first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • Hara Capital's Merck position peaked at $231K in Q4 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.